PanamaTimes

Sunday, Jan 19, 2025

Teva reaches proposed $4.25 bln settlement of U.S. opioid lawsuits

Teva reaches proposed $4.25 bln settlement of U.S. opioid lawsuits

Teva Pharmaceutical Industries (TEVA.TA) on Tuesday announced a $4.35 billion proposed nationwide settlement that could resolve thousands of lawsuits over the drugmaker's alleged role in the U.S. opioid epidemic.
The proposal calls for Teva to pay state and local governments up to $3.7 billion in cash over 13 years plus a contribution of $1.2 billion worth of the opioid overdose reversal drug naloxone. Israel-based Teva also will pay approximately $100 million to Native American tribes and pay attorneys fees incurred by the states, local governments and tribes.

Teva's proposed settlement would allow state and local governments to opt for additional cash in lieu of an allotment of the overdose medication, at a value of 20% of the drug's list price.

The settlement's cash portion is higher than Teva's chief executive suggested in May. CEO Kare Schultz told analysts at the time that he expected the company to pay around $2.6 billion in cash and medicine to reach a nationwide settlement.

The proposed settlement comes as Teva's New York traded shares have fallen 11% so far this year under a cloud of uncertainty over an opioid settlement.

Teva, which still has net debt of some $20 billion, had sought a deal featuring less cash and more medicines, but some states and counties were opposed, questioning the value of the medicine, produced far more cheaply than the prices used in the settlement agreements.

Iowa Attorney General Tom Miller, a lead negotiator for the states, called it "another major step in addressing the opioids crisis."

"We expect these funds to make a significant difference in preventing fatal overdoses and treating opioid addiction disorder," Miller said.

Teva's settlement is contingent on separate settlements by AbbVie's (ABBV.N) Allergan unit. Teva acquired Allergan's generic drugs business in 2016.

For the Teva deal to take effect, Allergan must reach its own nationwide opioid settlement, and the two companies must settle a dispute over the amount Allergan owes Teva for claims filed prior to the 2016 sale.

Allergan did not immediately respond to a request for comment.

The Teva settlement will not be finalized unless a sufficient number of state and local governments agree to accept the terms. Teva has already agreed to settlements with West Virginia, Texas, Florida, Rhode Island and Louisiana, and the value of those will be included in the proposed $3.05 billion cash payout.

The state of New York will not participate in the settlement, and continues to seek a judgment against Teva. A New York jury found the company responsible for the state's opioid crisis in December.

U.S. states, cities and counties filed more than 3,000 lawsuits against opioid manufacturers, distributors and pharmacies, accusing them of downplaying their addiction risk and failing to stop pills from being diverted for illegal use.

The U.S. opioid crisis has caused more than 500,000 overdose deaths over the past two decades, including more than 80,000 in 2021 alone, according to government data.

The company's insistence on including drugs as a major component of its opioid settlements has been a sticking point in past negotiations.

Teva in 2019 proposed to settle its nationwide opioid liability for $250 million in cash and $23 billion in contributed medicines that was rejected by state and local governments.
Newsletter

Related Articles

PanamaTimes
0:00
0:00
Close
Bill Ackman Praises Social Media Platform X as 'The New Media'
California Wildfires Set to Become Costliest in U.S. History
Chief Justice Roberts Warns Against Threats to Judicial Independence
Generation Z Faces Scrutiny Over Workplace Readiness
Democrats Call on Biden to Protect Controversial Temporary Protected Status Program
Trinidad and Tobago Declares State of Emergency as Murder Rates Surge
Migrant Children Abandoned at U.S.-Mexico Border
The Closure of the Global Engagement Center: Controversy, Claims, and Conclusions
The American Democrats Party Strives to Rise from the Ashes
Trump Nominates Kevin Marino Cabrera as Ambassador to Panama Amid Canal Dispute
Texas Congresswoman Kay Granger Located in Nursing Home Following Six Months of Inactivity
A large group of unauthorized migrants is traveling through Mexico with the aim of reaching the USA before Trump assumes office.
A Democrat Congresswoman with blue and black hair is having a breakdown over "President Musk."
Argentina Defies Predictions with Record $17 Billion Trade Surplus, But Is the Growth Sustainable?
Disney's High Seas Gamble: Navigating the Waters of Cruise Expansion
The Surprising Impact of Extreme Heat on Mexico's Youth
Polarization: The Word That Unites a Divided Era
Exoneration in the Subway: The Complexities of Self-Defense and Public Safety
The Tragic Passing of UnitedHealthcare CEO Highlights Corporate Security Challenges
Global Developments: Violence in Sinaloa, Political Chaos in the Bahamas, Venezuelan Voting Disputes, and a Major UK Drug Bust
OpenAI and Anduril: Charting AI's Path in Modern Warfare
The Pardon of Hunter Biden: A Symbol of Hypocrisy
Biden Crafted the Strategy Used by Trump
South Korea's Democracy Tested: President Yoon’s Martial Law Reversal Sparks Political Reckoning
Seoul Crisis: Yoon Suk Yeol's Martial Law Blunder Triggers Political Upheaval
Generative AI's Limited Impact on Elections Highlighted by Meta
France at the Precipice: Barnier’s Administration Confronts Unprecedented No-Confidence Vote
Jaguar Unveils Electric Concept Car, Type 00
White House Defends Presidential Pardon of Hunter Biden
xAI by Elon Musk: Transforming Ambition with a $50 Billion Valuation
President-elect Donald Trump, has announced on Truth Social that Kashyap "Kash" Patel, will be the next Director of the FBI
A Historic Milestone or Risky Precedent? The Assisted Dying Bill Splits both Parliament and the Nation in England and Wales
Trump's Tariff Threat Looms Large as Trudeau Heads to Mar-a-Lago for Talks
Canada's Oil Industry Faces Uncertainty Amidst Trump's Tariff Threat
World Court to Assess Global Legal Responsibilities on Climate Change
What the Pink Elephant Test Reveals About Thought Control
Trudeau Visits Trump in Florida Amid Rising Tariff Concerns
Is Elon Musk the Unofficial President of America?
Impact of Proposed US Tariffs on Canadian Oil Exports
U.S. policymakers face a contentious debate over whether to engage with Nicolás Maduro's regime in Venezuela.
COP29's Carbon Trading Deal Faces Major Criticisms
Indian Diplomats in Canada Monitored: Government Raises Alarm
Putin Warns Trump of Ongoing Safety Concerns
Claudia Sheinbaum Challenges Trump's Migration Claims
Insights from Dostoevsky: The Impact of Self-Deception
Trump Administration Nominees Face Threats, FBI Confirms
Elon Musk Criticizes Fighter Jets, Advocates for Drone Warfare
Kim Kardashian's Social Media Activity Fuels Political Speculation
An Examination of AI's Influence on Future Work and Life
Tulsi Gabbard's Contentious Nomination for Director of National Intelligence
×